Cancer Management and Research · 2018 · 26 citations · 24 references
MedicineMolecular BiologyOncologyMolecular OncologySignal TransductionTumor ProgressionBreast Cancer OncologyCancer Cell SignalingCancer ProgressionMalignant NeoplasmsOncogenic Signaling PathwaysSignal Transduction In CancerBreast Cancer ProgressionImmunohistochemical BiomarkersImmunohistochemical DetectionImmunohistochemical MarkersImmunohistochemical StainingMalignant Breast TumorsMalignant ProgressionSubcellular Protein Localization
Purpose: Current knowledge of TMEM17, a recently identified protein of the transmembrane (TMEM) family, is limited, especially with respect to its expression and biological functions in malignant tumors. This study analyzed TMEM17 expression in invasive breast cancer tissue and breast cell lines and its relevance to clinicopathological factors, and investigated the mechanisms underlying the biological effects of TMEM17 on breast cancer cells. Patients and methods: TMEM17 protein expression was determined in 20 freshly harvested specimens (tumor and paired normal tissues) by Western blotting. Immunohistochemical analysis was performed to determine the expression and subcellular localization of TMEM17 in samples from 167 patients (mean age, 49 years) diagnosed with invasive ductal carcinoma (38 with triple-negative breast cancer; 129 with non-triple-negative breast cancer) who underwent complete resection in the First Affiliated Hospital of China Medical University between 2011 and 2013. Furthermore, TMEM17 was knocked down by small interfering RNAs in breast cancer cell lines. Results: TMEM17 was found to be significantly upregulated in breast cancer tissues compared to the corresponding normal breast tissues by Western blotting ( p =0.015). Immunohistochemical analysis revealed that TMEM was significantly upregulated in invasive breast cancer cells compared to adjacent normal breast duct glandular epithelial cells (10.78% vs 76.05%, p <0.001), and its expression was closely related to the patient’s T-stage ( p =0.022), advanced TNM stages ( p =0.007), and lymph node metastasis ( p =0.012). After TMEM17 knockdown or overexpression in breast cancer cell lines, TMEM17 upregulated p-AKT, p-GSK3β, active β-catenin, and Snail, and downstream target proteins c-myc and cyclin D1, and downregulated E-cadherin, resulting in increased cancer cell proliferation, invasion, and migration. These effects were reversed by the AKT inhibitor LY294002. Conclusion: Our results indicate that TMEM17 is upregulated in breast cancer tissues and can promote malignant progression of breast cancer cells by activating the AKT/GSK3β signaling pathway. Keywords: proliferation, invasion, migration, β-catenin, Snail
24
Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2016 · 16.2K citations · Full text
Betsy Kohler, Recinda Sherman, Nadia Howlader et al. · JNCI Journal of the National Cancer Institute · 2015 · 924 citations · Full text
A Dynamic Protein Interaction Landscape of the Human Centrosome-Cilium Interface
Gagan D. Gupta, Étienne Coyaud, João Gonçalves et al. · Cell · 2015 · 570 citations · Full text
MKS5 and CEP290 Dependent Assembly Pathway of the Ciliary Transition Zone
Chunmei Li, Victor L. Jensen, Kwangjin Park et al. · PLoS Biology · 2016 · 136 citations · Full text